Loading clinical trials...
Loading clinical trials...
Clinical Trial, Randomized and Controlled With Placebo to Evaluate the Addition to an Antiretroviral Treatment of a Probiotic, Only or in Conjunction of a Pre-biotical, in Adults Infected by Hiv-1 With a cd4 Record Less Than 500 Cells / mm3
The main purpose of this study is to evaluate a therapy for the inflammaging (premature aging).
It's been demonstrated that the HIV-1 virus is associated to the reduction of the microbiota. Some studies suggest that because of this bacterial reduction, the premature aging appears. So this study aims to demonstrate that our probiotic can balance the microbiota as a preventive solution for the inflammaging.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Hospital Germans Trias i Pujol
Badalona, Barcelona, Spain
Start Date
December 18, 2017
Primary Completion Date
February 29, 2020
Completion Date
February 29, 2020
Last Updated
July 8, 2020
89
ACTUAL participants
Probiotic
DIETARY_SUPPLEMENT
Prebiotic
DIETARY_SUPPLEMENT
Placebo
DIETARY_SUPPLEMENT
Lead Sponsor
AB Biotics, SA
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07071623